Global GalNAc-based Drug Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global GalNAc-based Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 siRNA Based
  • 1.2.3 ASO Based
• 1.3 Market by Application
  • 1.3.1 Global GalNAc-based Drug Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Cardiovascular Diseases
  • 1.3.3 Metabolic Diseases
  • 1.3.4 Neurological Diseases
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global GalNAc-based Drug Market Perspective (2019-2030)
• 2.2 Global GalNAc-based Drug Growth Trends by Region
  • 2.2.1 Global GalNAc-based Drug Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 GalNAc-based Drug Historic Market Size by Region (2019-2024)
  • 2.2.3 GalNAc-based Drug Forecasted Market Size by Region (2025-2030)
• 2.3 GalNAc-based Drug Market Dynamics
  • 2.3.1 GalNAc-based Drug Industry Trends
  • 2.3.2 GalNAc-based Drug Market Drivers
  • 2.3.3 GalNAc-based Drug Market Challenges
  • 2.3.4 GalNAc-based Drug Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue GalNAc-based Drug by Players
  • 3.1.1 Global GalNAc-based Drug Revenue by Players (2019-2024)
  • 3.1.2 Global GalNAc-based Drug Revenue Market Share by Players (2019-2024)
• 3.2 Global GalNAc-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of GalNAc-based Drug, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global GalNAc-based Drug Market Concentration Ratio
  • 3.4.1 Global GalNAc-based Drug Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by GalNAc-based Drug Revenue in 2023
• 3.5 Global Key Players of GalNAc-based Drug Head office and Area Served
• 3.6 Global Key Players of GalNAc-based Drug, Product and Application
• 3.7 Global Key Players of GalNAc-based Drug, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 GalNAc-based Drug Breakdown Data by Type

• 4.1 Global GalNAc-based Drug Historic Market Size by Type (2019-2024)
• 4.2 Global GalNAc-based Drug Forecasted Market Size by Type (2025-2030)

5 GalNAc-based Drug Breakdown Data by Application

• 5.1 Global GalNAc-based Drug Historic Market Size by Application (2019-2024)
• 5.2 Global GalNAc-based Drug Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America GalNAc-based Drug Market Size (2019-2030)
• 6.2 North America GalNAc-based Drug Market Size by Type
  • 6.2.1 North America GalNAc-based Drug Market Size by Type (2019-2024)
  • 6.2.2 North America GalNAc-based Drug Market Size by Type (2025-2030)
  • 6.2.3 North America GalNAc-based Drug Market Share by Type (2019-2030)
• 6.3 North America GalNAc-based Drug Market Size by Application
  • 6.3.1 North America GalNAc-based Drug Market Size by Application (2019-2024)
  • 6.3.2 North America GalNAc-based Drug Market Size by Application (2025-2030)
  • 6.3.3 North America GalNAc-based Drug Market Share by Application (2019-2030)
• 6.4 North America GalNAc-based Drug Market Size by Country
  • 6.4.1 North America GalNAc-based Drug Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America GalNAc-based Drug Market Size by Country (2019-2024)
  • 6.4.3 North America GalNAc-based Drug Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe GalNAc-based Drug Market Size (2019-2030)
• 7.2 Europe GalNAc-based Drug Market Size by Type
  • 7.2.1 Europe GalNAc-based Drug Market Size by Type (2019-2024)
  • 7.2.2 Europe GalNAc-based Drug Market Size by Type (2025-2030)
  • 7.2.3 Europe GalNAc-based Drug Market Share by Type (2019-2030)
• 7.3 Europe GalNAc-based Drug Market Size by Application
  • 7.3.1 Europe GalNAc-based Drug Market Size by Application (2019-2024)
  • 7.3.2 Europe GalNAc-based Drug Market Size by Application (2025-2030)
  • 7.3.3 Europe GalNAc-based Drug Market Share by Application (2019-2030)
• 7.4 Europe GalNAc-based Drug Market Size by Country
  • 7.4.1 Europe GalNAc-based Drug Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe GalNAc-based Drug Market Size by Country (2019-2024)
  • 7.4.3 Europe GalNAc-based Drug Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China GalNAc-based Drug Market Size (2019-2030)
• 8.2 China GalNAc-based Drug Market Size by Type
  • 8.2.1 China GalNAc-based Drug Market Size by Type (2019-2024)
  • 8.2.2 China GalNAc-based Drug Market Size by Type (2025-2030)
  • 8.2.3 China GalNAc-based Drug Market Share by Type (2019-2030)
• 8.3 China GalNAc-based Drug Market Size by Application
  • 8.3.1 China GalNAc-based Drug Market Size by Application (2019-2024)
  • 8.3.2 China GalNAc-based Drug Market Size by Application (2025-2030)
  • 8.3.3 China GalNAc-based Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia GalNAc-based Drug Market Size (2019-2030)
• 9.2 Asia GalNAc-based Drug Market Size by Type
  • 9.2.1 Asia GalNAc-based Drug Market Size by Type (2019-2024)
  • 9.2.2 Asia GalNAc-based Drug Market Size by Type (2025-2030)
  • 9.2.3 Asia GalNAc-based Drug Market Share by Type (2019-2030)
• 9.3 Asia GalNAc-based Drug Market Size by Application
  • 9.3.1 Asia GalNAc-based Drug Market Size by Application (2019-2024)
  • 9.3.2 Asia GalNAc-based Drug Market Size by Application (2025-2030)
  • 9.3.3 Asia GalNAc-based Drug Market Share by Application (2019-2030)
• 9.4 Asia GalNAc-based Drug Market Size by Region
  • 9.4.1 Asia GalNAc-based Drug Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia GalNAc-based Drug Market Size by Region (2019-2024)
  • 9.4.3 Asia GalNAc-based Drug Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America GalNAc-based Drug Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America GalNAc-based Drug Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America GalNAc-based Drug Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Suzhou Ribo Life Science Co., Ltd
  • 11.1.1 Suzhou Ribo Life Science Co., Ltd Company Details
  • 11.1.2 Suzhou Ribo Life Science Co., Ltd Business Overview
  • 11.1.3 Suzhou Ribo Life Science Co., Ltd GalNAc-based Drug Introduction
  • 11.1.4 Suzhou Ribo Life Science Co., Ltd Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.1.5 Suzhou Ribo Life Science Co., Ltd Recent Development
• 11.2 Sirnaomics
  • 11.2.1 Sirnaomics Company Details
  • 11.2.2 Sirnaomics Business Overview
  • 11.2.3 Sirnaomics GalNAc-based Drug Introduction
  • 11.2.4 Sirnaomics Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.2.5 Sirnaomics Recent Development
• 11.3 Alnylam Pharmaceuticals
  • 11.3.1 Alnylam Pharmaceuticals Company Details
  • 11.3.2 Alnylam Pharmaceuticals Business Overview
  • 11.3.3 Alnylam Pharmaceuticals GalNAc-based Drug Introduction
  • 11.3.4 Alnylam Pharmaceuticals Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.3.5 Alnylam Pharmaceuticals Recent Development
• 11.4 Arrowhead
  • 11.4.1 Arrowhead Company Details
  • 11.4.2 Arrowhead Business Overview
  • 11.4.3 Arrowhead GalNAc-based Drug Introduction
  • 11.4.4 Arrowhead Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.4.5 Arrowhead Recent Development
• 11.5 Novo Nordisk (Dicerna)
  • 11.5.1 Novo Nordisk (Dicerna) Company Details
  • 11.5.2 Novo Nordisk (Dicerna) Business Overview
  • 11.5.3 Novo Nordisk (Dicerna) GalNAc-based Drug Introduction
  • 11.5.4 Novo Nordisk (Dicerna) Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.5.5 Novo Nordisk (Dicerna) Recent Development
• 11.6 Ionis
  • 11.6.1 Ionis Company Details
  • 11.6.2 Ionis Business Overview
  • 11.6.3 Ionis GalNAc-based Drug Introduction
  • 11.6.4 Ionis Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.6.5 Ionis Recent Development
• 11.7 Silence Therapeutics
  • 11.7.1 Silence Therapeutics Company Details
  • 11.7.2 Silence Therapeutics Business Overview
  • 11.7.3 Silence Therapeutics GalNAc-based Drug Introduction
  • 11.7.4 Silence Therapeutics Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.7.5 Silence Therapeutics Recent Development
• 11.8 Arbutus
  • 11.8.1 Arbutus Company Details
  • 11.8.2 Arbutus Business Overview
  • 11.8.3 Arbutus GalNAc-based Drug Introduction
  • 11.8.4 Arbutus Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.8.5 Arbutus Recent Development
• 11.9 Novartis
  • 11.9.1 Novartis Company Details
  • 11.9.2 Novartis Business Overview
  • 11.9.3 Novartis GalNAc-based Drug Introduction
  • 11.9.4 Novartis Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.9.5 Novartis Recent Development
• 11.10 Hitgen (Leaderna Therapeutics Ltd.)
  • 11.10.1 Hitgen (Leaderna Therapeutics Ltd.) Company Details
  • 11.10.2 Hitgen (Leaderna Therapeutics Ltd.) Business Overview
  • 11.10.3 Hitgen (Leaderna Therapeutics Ltd.) GalNAc-based Drug Introduction
  • 11.10.4 Hitgen (Leaderna Therapeutics Ltd.) Revenue in GalNAc-based Drug Business (2019-2024)
  • 11.10.5 Hitgen (Leaderna Therapeutics Ltd.) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global GalNAc-based Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of siRNA Based

Table 3. Key Players of ASO Based

Table 4. Global GalNAc-based Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global GalNAc-based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global GalNAc-based Drug Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global GalNAc-based Drug Market Share by Region (2019-2024)

Table 8. Global GalNAc-based Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global GalNAc-based Drug Market Share by Region (2025-2030)

Table 10. GalNAc-based Drug Market Trends

Table 11. GalNAc-based Drug Market Drivers

Table 12. GalNAc-based Drug Market Challenges

Table 13. GalNAc-based Drug Market Restraints

Table 14. Global GalNAc-based Drug Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global GalNAc-based Drug Market Share by Players (2019-2024)

Table 16. Global Top GalNAc-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GalNAc-based Drug as of 2023)

Table 17. Global GalNAc-based Drug Industry Ranking 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by GalNAc-based Drug Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of GalNAc-based Drug, Headquarters and Area Served

Table 20. Global Key Players of GalNAc-based Drug, Product and Application

Table 21. Global Key Players of GalNAc-based Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global GalNAc-based Drug Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global GalNAc-based Drug Revenue Market Share by Type (2019-2024)

Table 25. Global GalNAc-based Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global GalNAc-based Drug Revenue Market Share by Type (2025-2030)

Table 27. Global GalNAc-based Drug Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global GalNAc-based Drug Revenue Market Share by Application (2019-2024)

Table 29. Global GalNAc-based Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global GalNAc-based Drug Revenue Market Share by Application (2025-2030)

Table 31. North America GalNAc-based Drug Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America GalNAc-based Drug Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America GalNAc-based Drug Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America GalNAc-based Drug Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America GalNAc-based Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America GalNAc-based Drug Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America GalNAc-based Drug Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe GalNAc-based Drug Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe GalNAc-based Drug Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe GalNAc-based Drug Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe GalNAc-based Drug Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe GalNAc-based Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe GalNAc-based Drug Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe GalNAc-based Drug Market Size by Country (2025-2030) & (US$ Million)

Table 45. China GalNAc-based Drug Market Size by Type (2019-2024) & (US$ Million)

Table 46. China GalNAc-based Drug Market Size by Type (2025-2030) & (US$ Million)

Table 47. China GalNAc-based Drug Market Size by Application (2019-2024) & (US$ Million)

Table 48. China GalNAc-based Drug Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia GalNAc-based Drug Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia GalNAc-based Drug Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia GalNAc-based Drug Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia GalNAc-based Drug Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia GalNAc-based Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia GalNAc-based Drug Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia GalNAc-based Drug Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America GalNAc-based Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America GalNAc-based Drug Market Size by Country (2025-2030) & (US$ Million)

Table 63. Suzhou Ribo Life Science Co., Ltd Company Details

Table 64. Suzhou Ribo Life Science Co., Ltd Business Overview

Table 65. Suzhou Ribo Life Science Co., Ltd GalNAc-based Drug Product

Table 66. Suzhou Ribo Life Science Co., Ltd Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 67. Suzhou Ribo Life Science Co., Ltd Recent Development

Table 68. Sirnaomics Company Details

Table 69. Sirnaomics Business Overview

Table 70. Sirnaomics GalNAc-based Drug Product

Table 71. Sirnaomics Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 72. Sirnaomics Recent Development

Table 73. Alnylam Pharmaceuticals Company Details

Table 74. Alnylam Pharmaceuticals Business Overview

Table 75. Alnylam Pharmaceuticals GalNAc-based Drug Product

Table 76. Alnylam Pharmaceuticals Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 77. Alnylam Pharmaceuticals Recent Development

Table 78. Arrowhead Company Details

Table 79. Arrowhead Business Overview

Table 80. Arrowhead GalNAc-based Drug Product

Table 81. Arrowhead Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 82. Arrowhead Recent Development

Table 83. Novo Nordisk (Dicerna) Company Details

Table 84. Novo Nordisk (Dicerna) Business Overview

Table 85. Novo Nordisk (Dicerna) GalNAc-based Drug Product

Table 86. Novo Nordisk (Dicerna) Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 87. Novo Nordisk (Dicerna) Recent Development

Table 88. Ionis Company Details

Table 89. Ionis Business Overview

Table 90. Ionis GalNAc-based Drug Product

Table 91. Ionis Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 92. Ionis Recent Development

Table 93. Silence Therapeutics Company Details

Table 94. Silence Therapeutics Business Overview

Table 95. Silence Therapeutics GalNAc-based Drug Product

Table 96. Silence Therapeutics Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 97. Silence Therapeutics Recent Development

Table 98. Arbutus Company Details

Table 99. Arbutus Business Overview

Table 100. Arbutus GalNAc-based Drug Product

Table 101. Arbutus Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 102. Arbutus Recent Development

Table 103. Novartis Company Details

Table 104. Novartis Business Overview

Table 105. Novartis GalNAc-based Drug Product

Table 106. Novartis Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 107. Novartis Recent Development

Table 108. Hitgen (Leaderna Therapeutics Ltd.) Company Details

Table 109. Hitgen (Leaderna Therapeutics Ltd.) Business Overview

Table 110. Hitgen (Leaderna Therapeutics Ltd.) GalNAc-based Drug Product

Table 111. Hitgen (Leaderna Therapeutics Ltd.) Revenue in GalNAc-based Drug Business (2019-2024) & (US$ Million)

Table 112. Hitgen (Leaderna Therapeutics Ltd.) Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global GalNAc-based Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global GalNAc-based Drug Market Share by Type: 2023 VS 2030

Figure 3. siRNA Based Features

Figure 4. ASO Based Features

Figure 5. Global GalNAc-based Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global GalNAc-based Drug Market Share by Application: 2023 VS 2030

Figure 7. Cardiovascular Diseases Case Studies

Figure 8. Metabolic Diseases Case Studies

Figure 9. Neurological Diseases Case Studies

Figure 10. Other Case Studies

Figure 11. GalNAc-based Drug Report Years Considered

Figure 12. Global GalNAc-based Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global GalNAc-based Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global GalNAc-based Drug Market Share by Region: 2023 VS 2030

Figure 15. Global GalNAc-based Drug Market Share by Players in 2023

Figure 16. Global Top GalNAc-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GalNAc-based Drug as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by GalNAc-based Drug Revenue in 2023

Figure 18. North America GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America GalNAc-based Drug Market Share by Type (2019-2030)

Figure 20. North America GalNAc-based Drug Market Share by Application (2019-2030)

Figure 21. North America GalNAc-based Drug Market Share by Country (2019-2030)

Figure 22. United States GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe GalNAc-based Drug Market Share by Type (2019-2030)

Figure 26. Europe GalNAc-based Drug Market Share by Application (2019-2030)

Figure 27. Europe GalNAc-based Drug Market Share by Country (2019-2030)

Figure 28. Germany GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China GalNAc-based Drug Market Share by Type (2019-2030)

Figure 36. China GalNAc-based Drug Market Share by Application (2019-2030)

Figure 37. Asia GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia GalNAc-based Drug Market Share by Type (2019-2030)

Figure 39. Asia GalNAc-based Drug Market Share by Application (2019-2030)

Figure 40. Asia GalNAc-based Drug Market Share by Region (2019-2030)

Figure 41. Japan GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America GalNAc-based Drug Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America GalNAc-based Drug Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America GalNAc-based Drug Market Share by Country (2019-2030)

Figure 51. Brazil GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries GalNAc-based Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Suzhou Ribo Life Science Co., Ltd Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 58. Sirnaomics Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 60. Arrowhead Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 61. Novo Nordisk (Dicerna) Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 62. Ionis Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 63. Silence Therapeutics Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 64. Arbutus Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 65. Novartis Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 66. Hitgen (Leaderna Therapeutics Ltd.) Revenue Growth Rate in GalNAc-based Drug Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed